People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents | MicrobiomeTrials← Back to trialsNCT03520660
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2018-10-19Est. Completion: 2032-12-31
Enrollment target: 121 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Insulin ResistanceObesity
Background:
Obesity and related illnesses cause at least 2.8 million deaths each year worldwide. Few treatments exist f…
Bethesda, United StatesEst. completion Mar 1, 2030
Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. …
Bethesda, United StatesEst. completion Nov 30, 2027